Company: AEMD
Filing Date: 2025-04-08
Form Type: PRE 14A
Source: 0001683168-25-002332
Chunk: 27

Company: AETHLON MEDICAL INC
Filing Date: 2025-04-08
Form: PRE 14A
Chunk 27
---
 Reverse Stock Split.

Material Federal Income Tax Consequences of the Reverse Stock Split to U.S. Holders

The following is a summary of certain material U.S.
federal income tax consequences of the Reverse Stock Split that are generally expected to be applicable to U.S. Holders (as defined below)
of our common stock who hold their common shares as capital assets within the meaning of Section 1221 of the Internal Revenue Code of
1986, as amended (the “Code”) (generally property held for investment). The summary is based on the Code, applicable Treasury
Regulations promulgated thereunder, current administrative rulings and practices and judicial authorities as in effect on the date of
this proxy statement. Changes to the laws could alter the tax consequences described below, possibly with retroactive effect. We have
not sought and will not seek an opinion of counsel or a ruling from the Internal Revenue Service regarding the federal income tax consequences
of the Reverse Stock Split. This discussion is for general information only and does not discuss the tax consequences that may apply to
U.S. Holders in light of their particular circumstances or to U.S. Holders that may be subject to special rules, including without limitation
banks, financial institutions or insurance companies; brokers, dealers or traders in securities, commodities or currencies; tax-exempt
entities or organizations; regulated investment companies or real estate investment trusts, pension funds or retirement plans; certain
former citizens or long-term residents of the United States; persons that received shares of our common stock in connection with the exercise
of employee stock options or otherwise as compensation for the performance of services; persons that hold shares of our common stock as
part of a “hedging,” “integrated” or “conversion” transaction or as a position in a “straddle”
for U.S. federal income tax purposes; partnerships (including entities or arrangements classified as partnerships for U.S. federal income
tax purposes) or other pass-through entities, or holders that hold shares of our common stock through such an entity; persons who hold
our common stock as “qualified small business stock” within the meaning of Section 1202 of the Code or Section 1244 stock
for purposes of Section 1244 of the Code; persons who acquired their stock in a transaction subject to the gain rollover provisions of
Section 1045 of the Code, or persons whose “functional currency” is not the U.S. dollar. Moreover, this summary does not address
(i) the tax consequences of the